| No. | Analyte | Method | LLOQ (ng/mL) | Note |
| 1 |
11-Deoxycortisol |
HPLC/MS/MS |
0,02 |
determination of endogenous levels in postmenopausal women |
| 2 |
17-Carboxybudesonide |
HPLC/MS/MS |
0,1 |
in dog plasma |
| 3 |
17-Deacetylnorgestimate |
HPLC/MS/MS |
0,02 |
|
| 4 |
17-Hydroxyprogesterone |
HPLC/MS/MS |
0,02 |
determination of endogenous levels in postmenopausal women |
| 5 |
1-Adamantylethyloxy-3-morpholino-2-propanol |
HPLC/MS/MS |
0,05 |
|
| 6 |
2-Hydroxymethylmetronidazole |
HPLC/MS/MS |
4 |
|
| 7 |
5'-Deoxy-5-fluorocytidine |
HPLC/MS/MS |
25 |
|
| 8 |
5'-Deoxy-5-fluorouridine |
HPLC/MS/MS |
25 |
|
| 9 |
5-Fluorouracil |
HPLC/MS/MS |
5 |
|
| 10 |
5-Hydroxymethyltolterodine |
HPLC/MS/MS |
0,05 |
|
| 11 |
5-Hydroxypropafenone |
HPLC/MS/MS |
0,5 |
|
| 12 |
9-Hydroxyrisperidone |
HPLC/MS/MS |
0,1 |
|
| 13 |
Abiraterone |
HPLC/MS/MS |
0,2 |
|
| 14 |
Acetaminophen (paracetamol) |
HPLC/MS/MS |
250 |
|
| 15 |
Acetazolamide |
HPLC/MS/MS |
250 |
|
| 16 |
Acetylcysteine |
HPLC/MS/MS |
50 |
|
| 17 |
Acetylsalicylic acid |
HPLC/MS/MS |
25 |
common method with salicylic acid |
| 18 |
Acetylsalicylic acid |
HPLC/MS/MS |
5 |
common method with salicylic acid |
| 19 |
Aciclovir |
HPLC |
15 |
|
| 20 |
Aciclovir |
HPLC/MS/MS |
5 |
|
| 21 |
Agomelatine |
HPLC/MS/MS |
0,1 |
|
| 22 |
Aldosterone |
HPLC/MS/MS |
0,01 |
determination of endogenous levels in postmenopausal women |
| 23 |
Alendronate |
HPLC/MS/MS |
0,75 |
|
| 24 |
Amlodipine |
HPLC/MS/MS |
0,1 |
|
| 25 |
Amlodipine |
HPLC/MS/MS |
0,5 |
rat plasma direct injection |
| 26 |
Amlodipine |
chiral HPLC/MS/MS |
0,2 |
|
| 27 |
Amoxicillin |
HPLC/MS/MS |
100 |
|
| 28 |
Anagrelide |
HPLC/MS/MS |
0,075 |
|
| 29 |
Anastrozole |
HPLC/MS/MS |
0,5 |
|
| 30 |
Androstenedione |
HPLC/MS/MS |
0,02 |
determination of endogenous levels in postmenopausal women |
| 31 |
Aripiprazene |
HPLC/MS/MS |
0,1 |
|
| 32 |
Aripiprazole |
HPLC/MS/MS |
0,4 |
|
| 33 |
Atomoxetine |
HPLC/MS/MS |
5 |
|
| 34 |
Atorvastatin |
HPLC/MS/MS |
0,8 |
common method with ezetimibe |
| 35 |
Atorvastatin |
HPLC/MS/MS |
0,5 |
|
| 36 |
Atorvastatin |
HPLC/MS/MS |
0,25 |
common method with Ezetimibe and Ezetimibe Glucuronide |
| 37 |
Azithromycin |
HPLC/MS/MS |
4 |
|
| 38 |
Bendroflumethiazide |
HPLC/MS/MS |
0,4 |
|
| 39 |
Bicalutamide |
chiral HPLC/MS/MS |
1 |
|
| 40 |
Bicalutamide |
HPLC/MS/MS |
2 |
|
| 41 |
Bisoprolol |
HPLC/MS/MS |
0,5 |
|
| 42 |
Bosentan |
HPLC/MS/MS |
5 |
|
| 43 |
Budesonide |
HPLC/MS/MS |
0,05 |
in dog plasma |
| 44 |
Bumetanide |
HPLC |
4 |
|
| 45 |
Caffeine |
HPLC/MS/MS |
100 |
common method with paraxantine |
| 46 |
Candesartan |
HPLC/MS/MS |
2 |
|
| 47 |
Capecitabine |
HPLC/MS/MS |
100 |
|
| 48 |
Captopril (free) |
HPLC/MS/MS |
1 |
|
| 49 |
Captopril (free) |
HPLC |
15 |
|
| 50 |
Carbamazepine |
HPLC |
25 |
|
| 51 |
Carbocisteine |
HPLC/MS/MS |
50 |
|
| 52 |
Carvedilol |
HPLC/MS/MS |
1 |
|
| 53 |
Carvedilol metabolite M IV |
HPLC/MS/MS |
0,2 |
|
| 54 |
Cefditoren |
HPLC/MS/MS |
50 |
|
| 55 |
Cefixime |
HPLC/MS/MS |
100 |
|
| 56 |
Cefprozil |
HPLC/MS/MS |
100 |
|
| 57 |
Cefuroxime |
HPLC/MS/MS |
50 |
|
| 58 |
Celecoxib |
HPLC/MS/MS |
10 |
|
| 59 |
Chlorambucil |
HPLC/MS/MS |
1 |
|
| 60 |
Chlorthalidone |
HPLC/MS/MS |
2 |
|
| 61 |
Cilostazol |
HPLC/MS/MS |
50 |
|
| 62 |
Ciprofloxacine |
HPLC/MS/MS |
50 |
|
| 63 |
Clarithromycin |
HPLC/MS/MS |
50 |
|
| 64 |
Clobazam |
HPLC/MS/MS |
1 |
|
| 65 |
Clozapin |
GC/MS |
0,6 |
|
| 66 |
C-peptide |
ELISA |
0,2 |
|
| 67 |
Dapagliflozin |
HPLC/MS/MS |
2 |
common method with linagliptin |
| 68 |
Darunavir |
HPLC/MS/MS |
200 |
|
| 69 |
Dasatinib |
HPLC/MS/MS |
0,25 |
|
| 70 |
Desethyloxybutynin |
GC/MS |
2 |
|
| 71 |
Desethyloxybutynin |
HPLC |
4 |
|
| 72 |
Desloratadine |
HPLC/MS/MS |
0,05 |
|
| 73 |
Desmethylfluoxetine |
GC/MS |
0,4 |
|
| 74 |
Dexamethasone |
HPLC/MS/MS |
0,25 |
|
| 75 |
Dexketoprofen |
HPLC/MS/MS |
50 |
|
| 76 |
Dextromethorphan |
HPLC/MS/MS |
0,01 |
|
| 77 |
Diclofenac |
HPLC/MS/MS |
5 |
|
| 78 |
Didanosine |
HPLC/MS/MS |
20 |
|
| 79 |
Dienogest |
HPLC/MS/MS |
1 |
|
| 80 |
Diosmetin-3-O-glucuronide |
HPLC/MS/MS |
0,05 |
|
| 81 |
Donepezil |
HPLC/MS/MS |
0,2 |
|
| 82 |
Doxazosin |
HPLC |
0,4 |
|
| 83 |
Doxylamine |
HPLC/MS/MS |
|
|
| 84 |
Drospirenone |
HPLC/MS/MS |
0,5 |
|
| 85 |
Drotaverine |
HPLC/MS/MS |
3 |
|
| 86 |
Duloxetine |
HPLC/MS/MS |
0,5 |
|
| 87 |
Dutasteride |
HPLC/MS/MS |
0,05 |
|
| 88 |
Emoxipine |
HPLC/MS/MS |
5 |
|
| 89 |
Enalapril |
HPLC/MS/MS |
1 |
|
| 90 |
Enalaprilat |
HPLC/MS/MS |
1,2 |
|
| 91 |
Entecavir |
HPLC/MS/MS |
0,05 |
|
| 92 |
Eplerenon |
HPLC/MS/MS |
10 |
|
| 93 |
Epoxycarbamazepin |
HPLC |
25 |
|
| 94 |
Erlotinib |
HPLC/MS/MS |
5 |
|
| 95 |
Escitalopram |
HPLC/MS/MS |
0,25 |
|
| 96 |
Esomeprazole |
HPLC/MS/MS |
10 |
|
| 97 |
Estradiol |
HPLC/MS/MS |
0,0008 |
determination of endogenous levels in postmenopausal women |
| 98 |
Estrone |
HPLC/MS/MS |
0,001 |
determination of endogenous levels in postmenopausal women |
| 99 |
Estrone sulfate |
HPLC/MS/MS |
0,01 |
determination of endogenous levels in postmenopausal women |
| 100 |
Eszopiclon |
HPLC/MS/MS |
0,25 |
|
| 101 |
Ethinylestradiol |
HPLC/MS/MS |
0,001 |
|
| 102 |
Ethylmethylhydroxypyridine |
HPLC/MS/MS |
0,25 |
|
| 103 |
Ethylmethylhydroxypyridine |
HPLC/MS/MS |
1 |
|
| 104 |
Etoricoxib |
HPLC/MS/MS |
5 |
|
| 105 |
Everolimus |
HPLC/MS/MS |
1 |
in whole blood |
| 106 |
Exemestane |
HPLC/MS/MS |
0,25 |
|
| 107 |
Ezetimibe |
HPLC/MS/MS |
0,04 |
common method with ezetimibe glucuronide |
| 108 |
Ezetimibe |
HPLC/MS/MS |
0,08 |
common method with atorvastatin |
| 109 |
Ezetimibe |
HPLC/MS/MS |
0,05 |
common method with simvastatin |
| 110 |
Ezetimibe |
HPLC/MS/MS |
0,05 |
common method with atorvastatin and ezetimibe glucuronide |
| 111 |
Ezetimibe glucuronide |
HPLC/MS/MS |
1 |
common method with atorvastarin and ezetimibe |
| 112 |
Ezetimibe glucuronide |
HPLC/MS/MS |
0,8 |
common method with ezetimibe |
| 113 |
Ezetimibe glucuronide |
HPLC/MS/MS |
0,8 |
common method with atorvastatin |
| 114 |
Famotidine |
HPLC |
2,5 |
|
| 115 |
Fenpiverinium |
HPLC/MS/MS |
0,03 |
common method with ketorolac and pitofenone |
| 116 |
Fenspiride |
HPLC/MS/MS |
1 |
|
| 117 |
Fenspiride |
HPLC/MS/MS |
1 |
|
| 118 |
Fingolimod |
HPLC/MS/MS |
0,01 |
in whole blood |
| 119 |
Fluoxetine |
GC/MS |
0,4 |
|
| 120 |
Flupirtine |
HPLC/MS/MS |
20 |
|
| 121 |
Flupirtine |
HPLC/MS/MS |
10 |
|
| 122 |
Flurbiprofen |
HPLC/MS/MS |
100 |
|
| 123 |
Fluvoxamine |
HPLC |
1,5 |
|
| 124 |
Fosfomycin |
HPLC/MS/MS |
500 |
|
| 125 |
Fulvestrant |
HPLC/MS/MS |
0,2 |
|
| 126 |
Furagin (Furazidine) |
HPLC/MS/MS |
2 |
|
| 127 |
Furagin (Furazidine) |
HPLC/MS/MS |
100 |
|
| 128 |
Ganciclovir |
HPLC/MS/MS |
50 |
|
| 129 |
Gentamicin |
HPLC/MS/MS |
|
in animals samples |
| 130 |
Glargine |
ELISA |
7,5 µU/mL |
|
| 131 |
Gliclazide |
HPLC/MS/MS |
20 |
|
| 132 |
Glimepiride |
HPLC/MS/MS |
1 |
|
| 133 |
Glucosamine |
HPLC/MS/MS |
10 |
|
| 134 |
Glycoursodeoxycholic acid |
HPLC/MS/MS |
20 |
endogenous compound |
| 135 |
Hydrochlorothiazide |
HPLC/MS/MS |
0,2 |
|
| 136 |
Hydrochlorothiazide |
HPLC/MS/MS |
0,5 |
|
| 137 |
Hydrocortisone |
HPLC/MS/MS |
10 |
endogenous compound |
| 138 |
Hydroxyurea |
HPLC/MS/MS |
250 |
|
| 139 |
Ibuprofen |
HPLC/MS/MS |
500 |
|
| 140 |
Ibuprofen |
HPLC/MS/MS |
250 |
|
| 141 |
Isoprinosine (DIP) |
HPLC/MS/MS |
10 |
|
| 142 |
Isoprinosine (PAcBA) |
HPLC/MS/MS |
50 |
|
| 143 |
Imatinib |
HPLC/MS/MS |
20 |
|
| 144 |
Indapamide |
HPLC/MS/MS |
1 |
in whole blood |
| 145 |
Insulin |
ELISA |
6,25 µU/mL |
|
| 146 |
Insulin |
ELISA |
12,5 µU/mL |
|
| 147 |
Insulin |
ELISA |
4 µU/mL |
|
| 148 |
Ipidacrine |
HPLC/MS/MS |
0,1 |
|
| 149 |
Irbesartan |
HPLC/MS/MS |
5 |
|
| 150 |
Isoprinosine (DIP) |
HPLC/MS/MS |
80 |
|
| 151 |
Isoprinosine (PAcBA) |
HPLC/MS/MS |
200 |
|
| 152 |
Ivabradine |
HPLC/MS/MS |
0,25 |
|
| 153 |
Ketorolac |
HPLC/MS/MS |
3 |
common method with fenpiverinium and pitofenone |
| 154 |
Ketorolac |
HPLC/MS/MS |
30 |
|
| 155 |
Lacidipine |
HPLC/MS/MS |
0,02 |
|
| 156 |
Lenalidomide |
HPLC/MS/MS |
2 |
|
| 157 |
Letrozole |
HPLC/MS/MS |
0,5 |
|
| 158 |
Letrozole |
HPLC/MS/MS |
1 |
|
| 159 |
Levetiracetam |
HPLC/MS/MS |
200 |
|
| 160 |
Levocetirizine |
HPLC/MS/MS |
2,5 |
|
| 161 |
Levocetirizine |
HPLC/MS/MS |
1 |
common method with montelucast |
| 162 |
Levofloxacine |
HPLC/MS/MS |
100 |
|
| 163 |
Levothyroxine |
HPLC/MS/MS |
10 |
endogenous compound |
| 164 |
Linagliptin |
HPLC/MS/MS |
0,1 |
common method with dapagliflozin |
| 165 |
Linezolid |
HPLC/MS/MS |
200 |
|
| 166 |
Liothyronine |
HPLC/MS/MS |
0,25 |
endogenous compound |
| 167 |
Lisinopril |
HPLC/MS/MS |
1 |
|
| 168 |
Lornoxicam |
HPLC/MS/MS |
20 |
|
| 169 |
Losartan |
HPLC/MS/MS |
3 |
|
| 170 |
Lovastatin |
GC/MS/MS |
0,15 |
|
| 171 |
Lovastatin hydroxyacid |
GC/MS/MS |
0,15 |
|
| 172 |
Mebeverine acid |
HPLC/MS/MS |
10 |
|
| 173 |
Mebeverine acid, desmethyl |
HPLC/MS/MS |
10 |
|
| 174 |
Megestrol acetate |
HPLC/MS/MS |
1 |
|
| 175 |
Meldonium |
HPLC/MS/MS |
100 |
|
| 176 |
Meloxicam |
HPLC |
30 |
|
| 177 |
Meloxicam |
HPLC/MS/MS |
20 |
|
| 178 |
Memantine |
HPLC/MS/MS |
0,2 |
|
| 179 |
Metformin |
HPLC/MS/MS |
10 |
|
| 180 |
Methyldopa |
HPLC/MS/MS |
20 |
|
| 181 |
Methylsulfoxyethanol (MSE) |
HPLC/MS/MS |
200 |
|
| 182 |
Metoprolol |
HPLC/MS/MS |
1 |
|
| 183 |
Metronidazole |
HPLC/MS/MS |
20 |
|
| 184 |
Mianserin |
chiral HPLC/MS/MS |
0,2 |
|
| 185 |
Micophenolic acid |
HPLC/MS/MS |
500 |
|
| 186 |
Mildronate |
HPLC/MS/MS |
50 |
|
| 187 |
Milnacipran |
HPLC/MS/MS |
2 |
|
| 188 |
Misoprostol acid |
HPLC/MS/MS |
0,05 |
|
| 189 |
Misoprostol acid |
HPLC/MS/MS |
0,025 |
|
| 190 |
Moclobemide |
HPLC |
30 |
|
| 191 |
Montelukast |
HPLC/MS/MS |
1 |
|
| 192 |
Montelukast |
HPLC/MS/MS |
2 |
common method with levocetirizine |
| 193 |
Moxifloxacin |
HPLC/MS/MS |
50 |
|
| 194 |
Moxonidine |
HPLC/MS/MS |
0,02 |
|
| 195 |
N,N-Didesmethyl Sibutramine |
HPLC/MS/MS |
0,1 |
common method with N-desmethyl sibutramine and sibutramine |
| 196 |
N-Desmethyl Sibutramine |
HPLC/MS/MS |
0,1 |
common method with N,N-Didesmethyl sibutramine and sibutramine |
| 197 |
Naftidrofuryl |
HPLC |
200 |
|
| 198 |
Naproxen |
HPLC/MS/MS |
200 |
|
| 199 |
Naproxen |
HPLC/MS/MS |
10 |
in urine |
| 200 |
Naproxen |
HPLC/MS/MS |
500 |
|
| 201 |
Nebivolol |
HPLC/MS/MS |
0,02 |
|
| 202 |
Nerofe |
HPLC/MS/MS |
1 000,00 |
in dog plasma |
| 203 |
Nevirapine |
HPLC/MS/MS |
25 |
|
| 204 |
Nitrofurantoin |
HPLC/MS/MS |
2 |
|
| 205 |
Norgestimate |
HPLC/MS/MS |
0,0004 |
|
| 206 |
O-desmethyltramadol |
HPLC/MS/MS |
0,5 |
|
| 207 |
O-desmethylvenlafaxine |
HPLC/MS/MS |
0,5 |
|
| 208 |
O-hydroxy atorvastatin |
HPLC/MS/MS |
0,4 |
common method with ezetimibe |
| 209 |
Olanzapine |
HPLC/MS/MS |
0,1 |
|
| 210 |
Olanzapine |
HPLC/MS/MS |
0,25 |
|
| 211 |
Olmesartan |
HPLC/MS/MS |
10 |
|
| 212 |
Omeprazole |
HPLC/MS/MS |
10 |
|
| 213 |
Ondansetron |
HPLC/MS/MS |
1 |
|
| 214 |
Oracin |
HPLC |
20 |
|
| 215 |
Ornidazole |
HPLC/MS/MS |
200 |
|
| 216 |
Oseltamivir |
HPLC/MS/MS |
0,5 |
|
| 217 |
Oxybutynin |
GC/MS |
0,2 |
|
| 218 |
Paliperidon |
HPLC/MS/MS |
0,2 |
|
| 219 |
Paraxantine |
HPLC/MS/MS |
100 |
common method with caffeine |
| 220 |
Paroxetine |
HPLC/MS/MS |
0,1 |
|
| 221 |
Paroxetine |
HPLC/MS/MS |
0,025 |
|
| 222 |
Paroxetine metabolite |
HPLC/MS/MS |
0,2 |
|
| 223 |
Pentoxifylline |
HPLC/MS/MS |
1 |
|
| 224 |
Pentoxifylline metabolite M1 |
HPLC/MS/MS |
2 |
|
| 225 |
Pentoxifylline metabolite M5 |
HPLC/MS/MS |
10 |
|
| 226 |
Perindopril |
HPLC/MS/MS |
2,5 |
|
| 227 |
Perindoprilate |
HPLC/MS/MS |
0,25 |
|
| 228 |
p-hydroxy atorvastatin |
HPLC/MS/MS |
0,04 |
common method with ezetimibe |
| 229 |
Pioglitazone |
HPLC/MS/MS |
10 |
|
| 230 |
Pioglitazone metabolite M IV |
HPLC/MS/MS |
5 |
|
| 231 |
Piracetam |
HPLC/MS/MS |
500 |
|
| 232 |
Pitofenone |
HPLC/MS/MS |
1 |
common method with ketorolac and fenpiverinium |
| 233 |
Pizotifen |
GC/MS/MS |
0,05 |
|
| 234 |
Pramipexole |
HPLC/MS/MS |
0,02 |
|
| 235 |
Pramipexole |
HPLC/MS/MS |
0,01 |
|
| 236 |
Prednisolone |
HPLC/MS/MS |
3 |
|
| 237 |
Pregabalin |
HPLC/MS/MS |
50 |
|
| 238 |
Pridinol |
HPLC/MS/MS |
0,2 |
|
| 239 |
Pridinol |
HPLC/MS/MS |
1 |
in urine |
| 240 |
Propafenone |
HPLC/MS/MS |
1 |
|
| 241 |
Propiverine |
HPLC/MS/MS |
0,5 |
|
| 242 |
Quetiapine |
HPLC/MS/MS |
1 |
|
| 243 |
Raloxifene |
HPLC/MS/MS |
0,01 |
|
| 244 |
Raloxifene-4-glucoronide |
HPLC/MS/MS |
1 |
|
| 245 |
Raloxifene-6-glucoronide |
HPLC/MS/MS |
0,5 |
|
| 246 |
Ramipril |
HPLC/MS/MS |
0,2 |
|
| 247 |
Ramipril |
HPLC/MS/MS |
0,4 |
|
| 248 |
Ramipril |
HPLC/MS/MS |
0,05 |
in dog plasma |
| 249 |
Ramiprilate |
HPLC/MS/MS |
0,2 |
|
| 250 |
Ramiprilate |
HPLC/MS/MS |
0,5 |
in dog plasma |
| 251 |
Ranitidin |
HPLC |
10 |
|
| 252 |
Ranolazine |
HPLC/MS/MS |
25 |
|
| 253 |
Rasagiline |
HPLC/MS/MS |
0,1 |
|
| 254 |
Rebamipide |
HPLC/MS/MS |
4 |
|
| 255 |
Ribavirin |
HPLC/MS/MS |
3 |
|
| 256 |
Risperidone |
HPLC/MS/MS |
0,1 |
|
| 257 |
Ritonavir |
HPLC/MS/MS |
20 |
|
| 258 |
Rizatriptan |
HPLC/MS/MS |
0,1 |
|
| 259 |
Ropinirole |
HPLC/MS/MS |
0,1 |
|
| 260 |
Rosuvastatin |
HPLC/MS/MS |
0,05 |
|
| 261 |
Salicylic acid |
HPLC |
200 |
|
| 262 |
Salicylic acid |
HPLC/MS/MS |
100 |
common method with acetylsalicylic acid |
| 263 |
Salicylic acid |
HPLC/MS/MS |
20 |
common method with acetylsalicylic acid |
| 264 |
Sibutramine |
HPLC/MS/MS |
0,1 |
common method with N,N-didesmethyl sibutramine and N-desmethyl sibutramine |
| 265 |
Sildenafil |
HPLC/MS/MS |
1 |
|
| 266 |
Sildenafil |
HPLC/MS/MS |
5 |
|
| 267 |
Simvastatin |
GC/MS/MS |
0,5 |
|
| 268 |
Simvastatin |
LC/MS/MS |
0,5 |
|
| 269 |
Simvastatin |
LC/MS/MS |
0,2 |
common method with ezetimibe |
| 270 |
Simvastatin |
LC/MS/MS |
0,2 |
|
| 271 |
Simvastatin hydroxyacid |
GC/MS/MS |
0,1 |
|
| 272 |
Simvastatin hydroxyacid |
LC/MS/MS |
0,1 |
|
| 273 |
Simvastatin hydroxyacid |
LC/MS/MS |
0,05 |
common method with ezetimibe |
| 274 |
Sitagliptin |
HPLC/MS/MS |
1 |
|
| 275 |
Solifenacin |
HPLC/MS/MS |
0,2 |
|
| 276 |
Tadalafil |
HPLC/MS/MS |
5 |
|
| 277 |
Tamsulosin |
HPLC/MS/MS |
0,2 |
|
| 278 |
Tamsulosin |
HPLC/MS/MS |
0,1 |
|
| 279 |
Tamsulosin |
HPLC/MS/MS |
0,05 |
|
| 280 |
Tauroursodeoxycholic acid |
HPLC/MS/MS |
5 |
endogenous compound |
| 281 |
Telmisartan |
HPLC/MS/MS |
2 |
|
| 282 |
Tenofovir |
HPLC/MS/MS |
5 |
|
| 283 |
Terbinafine |
HPLC |
20 |
|
| 284 |
Thiocolchicoside metabolite M1 |
HPLC/MS/MS |
1 |
|
| 285 |
Tianeptine |
chiral HPLC/MS/MS |
2 |
|
| 286 |
Ticagrelor |
HPLC/MS/MS |
5 |
|
| 287 |
Tiotropium |
HPLC/MS/MS |
0,0001 |
|
| 288 |
Tolperisone |
HPLC/MS/MS |
0,5 |
|
| 289 |
Tolterodine |
HPLC/MS/MS |
0,05 |
|
| 290 |
Torasemide |
HPLC/MS/MS |
20 |
|
| 291 |
Toremifene |
HPLC/MS/MS |
2 |
|
| 292 |
Tramadol |
GC/MS |
6 |
|
| 293 |
Tramadol |
HPLC/MS/MS |
5 |
|
| 294 |
Trimetazidine |
HPLC/MS/MS |
0,5 |
|
| 295 |
Ulipristal |
HPLC/MS/MS |
0,2 |
|
| 296 |
Uridine |
HPLC/MS/MS |
150 |
endogenous compound |
| 297 |
Ursodeoxycholic acid |
HPLC/MS/MS |
10 |
endogenous compound |
| 298 |
Valganciclovir |
HPLC/MS/MS |
5 |
|
| 299 |
Valproic acid |
HPLC/MS/MS |
250 |
|
| 300 |
Valsartan |
HPLC/MS/MS |
50 |
|
| 301 |
Vardenafil |
HPLC/MS/MS |
0,25 |
|
| 302 |
Venlafaxine |
HPLC/MS/MS |
10 |
in rat plasma |
| 303 |
Venlafaxine |
HPLC/MS/MS |
0,5 |
|
| 304 |
Vildagliptin |
HPLC/MS/MS |
2 |
|
| 305 |
Voriconazole |
HPLC/MS/MS |
5 |
|
| 306 |
Warfarin |
HPLC |
20 |
|
| 307 |
Zidovudine |
HPLC/MS/MS |
25 |
|
| 308 |
Zolpidem |
HPLC |
1 |
plasma direct injection |
| 309 |
Zopiclon |
HPLC |
4 |
|
